Perimetric Testing With Virtual Reality

Envision Health Technologies, Inc.

Status: Enrolling

Conditions: Glaucoma

Treatments: Diagnostic Test: Perimetric test

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT06549010

ENV1

Details and patient eligibility

About

Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility.

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.

Full description

Procedures:

1. Ophthalmic screening:

   (a) Visual acuity, slit lamp exam, rebound tonometry (all subjects)

2. OCT examination of the study eye with the Topcon Maestro2 Optical Coherence Tomography (OCT):

   (a) Standard Retinal Nerve Fiber Layer (RNFL), Optic Disc and Ganglion Cell Complex (GCC) scan patterns (i) Fundus photo is automatically obtained. (b) Abnormalities consistent with ophthalmic disease will be an exclusion for the healthy group of subjects. Reasonable and common artifacts that do not significantly impair the scan report will be accepted.

   (c) OCT abnormalities consistent with glaucoma are expected on the 30 glaucoma subjects.

3. Once eligible, each patient will perform four (4) visual field tests:

   (a) once with the HFA Swedish Interactive Threshold Algorithm (SITA) Standard 24-2 pattern (i) Reliability criteria: False Positives no higher than 15% (b) three tests with the VR headset: (i) two tests with ZEST strategy (ii) one test with gamified ZEST strategy (c) Counter-balancing will be used to determine the order of (a) and (b). In particular, a study participant will either start with the HFA visual field test and then proceed to the three tests with the VR headset; or, start with the three VR tests and finish with the HFA visual field test. The sequence of the visual field tests for each study ID will be provided by the sponsor.

Enrollment: 60 estimated patients

Sex: All

Ages: 25 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion / Exclusion Criteria:

1. Age range: 25-70 years

2. For normal subjects:

   1. Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects: e.g. retina pathology, glaucoma, cataracts, keratoconus
   2. No ocular surgery other than cataract surgery within 6 months prior to the study visit

3. For glaucoma subjects:

   1. Patient has a diagnosis of primary open-angle glaucoma
   2. Patient is free of any other current or prior ophthalmic pathologies that would potentially cause visual field defects.
   3. No other ocular surgery other than glaucoma or cataract surgery within 6 months prior to the study visit
   4. No IOP lower than 10 mm/Hg or higher than 30 mm/Hg

4. Refractive Error:

   1. Sphere = up to -6.00 D to and up +3.00
   2. Cylinder = up to -3.00 is common

5. No past refractive eye surgery

6. No Multifocal or phakic (ICLs) IOL; no multifocal CLs

7. One eligible eye

8. Ability to sit for standard VF bowl exam. Ability to wear VR perimetry headset device.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Healthy subjects

Other group

Description:

30 healthy subjects

Treatment:

Diagnostic Test: Perimetric test

Glaucoma subjects

Other group

Description:

30 glaucoma patients, 10 mild, 10 moderate, 10 severe

Treatment:

Diagnostic Test: Perimetric test